Stratagene Stock Tumbles, But the Index Remains Up | GenomeWeb

Returning from a two-week hiatus, the BCW Index gained 1.8 percent for the past three weeks Stratagene posted by far the biggest loss for both the past week and the three-week tracking period, after a jury found the firm had willfully infringed patents held by Third Wave Technologies and ordered Stratagene to pay damages of $5.3 million (see related article). For the four days ended Tuesday, Stratagene's shares fell 16.6 percent, and for the three-week tracking period, the shares dropped 18.7 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."